Patent · US Active

Pyrimidine derivatives which are CGRP—antagonists

US8952014B2 · kind B2 · utility

3Cited by

2References

8Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Dirk Gottschling · Mittelbiberach, DE
Henri Doods · Warthausen, DE
Annekatrin Heimann · Biberach, DE
Stephan Georg Mueller · Warthausen, DE
Klaus Rudolf · Warthausen, DE
Gerhard Schaenzle · Biberach, DE
Dirk Stenkamp · Biberach, DE

Key dates

Filing date	Dec 17, 2009
Grant date	Feb 10, 2015
Priority date	—
Expiry date	May 10, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the new compounds of general formula Iwherein A, U, V, X, Y, R1, R2 and R3 are defined as stated hereinafter, the tautomers, the isomers thereof, the diastereomers, the enantiomers, the hydrates, the mixtures and the salts thereof as well as the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, their use and processes for preparing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.